Who is sponsoring NCT05251103?

NCT05251103 is sponsored by National Taiwan Sport University.

What drugs are being tested in NCT05251103?

Interventions in NCT05251103: time-restricted feeding trial.

What condition does NCT05251103 study?

NCT05251103 studies Time-restricted Feeding, Postprandial Lipemia.

Is NCT05251103 still recruiting?

NCT05251103 is currently completed. Last updated 22 February 2022.

Last reviewed 2022-02-22 · How we verify

NCT05251103

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Different Methods for Modulating Postprandial Fat Oxidation on Postprandial Lipemia the Next Day

Completed NA Last updated 22 February 2022

What this trial tests

NA trial testing time-restricted feeding trial in Time-restricted Feeding in 8 participants. Completed in 3 February 2022.

Timeline

4 June 2021

Primary endpoint
3 February 2022

3 February 2022

Quick facts

Lead sponsor	National Taiwan Sport University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	basic science
Enrollment	8
Start date	4 June 2021
Primary completion	3 February 2022
Estimated completion	3 February 2022
Sites	1 location across Taiwan

Drugs / interventions tested

time-restricted feeding trial

Conditions studied

Time-restricted Feeding — all drugs for Time-restricted Feeding →
Postprandial Lipemia — all drugs for Postprandial Lipemia →

Sponsor

National Taiwan Sport University

Who can join

20 and older, male only, with Time-restricted Feeding or Postprandial Lipemia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background: Studies have revealed that time-restricted feeding affects the fat oxidation rate; however, its effects on the fat oxidation rate and hyperlipidemia following high-fat meals are unclear. This study investigated the effects of 5-day time-restricted feeding on the fat oxidation rate and postprandial lipemia following high fat meals. Methods: In this random crossover experimental study, eight healthy male adults were included each in the 5-day time-restricted feeding trial and the control trial. The meals of the time-restricted feeding trial were provided at 12:00, 16:00, and 20:00. The meals of the control trial were provided at 08:00, 14:00, and 20:00. The contents of the meals of both trials were the same, and the calories of the meals met the 24-hour energy requirement of the participants. After 5 days of the intervention, the participants consumed high-fat meals on the sixth day, and their physiological changes were determined.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

5 days of time-restricted feeding increases fat oxidation rate but not affect postprandial lipemia: a crossover trial.
Chiu CH, Chen CH, Wu MH, Lan PT, et al · · 2022 · cited 8× · PMID 35661801 · DOI 10.1038/s41598-022-13387-8

Verify or expand the search:

Other National Taiwan Sport University trials

Trials by the same sponsor.

NCT07412951 — Effects of Caffeine and Shot Put Performance · NA · active not recruiting
NCT07175766 — Dachundou No Sugar Added Soymilk for Lipid Modulation · NA · completed
NCT06902662 — Sanghuangporus Sanghuang Supplementation to Improve Anti-Fatigue Performance in Healthy Adults · NA · completed
NCT06670742 — Gut-muscle Axis: Exploring the Gut Microbiota Influences Host Energy Sources and Exercise Performance · NA · not yet recruiting
NCT06638372 — Caffeinated Chewing Gum on Special Forces Performance · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05251103 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by National Taiwan Sport University
Last refreshed: 22 February 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05251103.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing